Request Trial

Biotech news

Reset all filters
Geography
Company
Refine search
GSK: Pfizer, BioNTech ‘reaped billions of dollars’ from stealing COVID-19 patents
Americas
GSK: Pfizer, BioNTech ‘reaped billions of dollars’ from stealing COVID-19 patents
New claim from GlaxoSmithKline is latest in litany of lawsuits against rivals | US lawsuit, potentially worth “billions of dollars”, is filed as UK trial kicks off between Moderna, Pfizer and BioNTech.   26 April 2024
Meeting the cell and gene therapy scale-up challenge
Biotech
Meeting the cell and gene therapy scale-up challenge
Improving patient access is a UN goal but for companies transitioning from trials to full-scale production, IP is essential, explains Katherine Collins of Mewburn Ellis.   25 April 2024
Bio-Techne loses UK patent bid and heads to UPC
Biotech
Bio-Techne loses UK patent bid and heads to UPC
UK High Court invalidates two patents due to “overwhelming evidence” supplied by defendant | Biotech firm files same claims in Netherlands division of UPC on same day.   25 April 2024
Biotech
US Supreme Court denies Vanda's bid to revive sleep drug patents
Vanda denied opportunity to revive patents for its sleep-disorder drug in dispute against Teva | Decision also rejects revisiting the 2007 case, KSR International v Teleflex, concerning the issue of obviousness in patent claims.   23 April 2024
Biotech
ProQR defends RNA editing platform at EPO
Opposition Division upholds patent challenged by 'straw men' | Dutch biotech has seen off challenges to patents in Europe and Japan.   23 April 2024
Biotech
Crafting a claim for AI in medtech: Two case studies
As artificial intelligence creates a complex legal landscape for healthcare and medtech, Janine Swarbrick of HGF explores two case studies that shed light on how to claim an AI invention.   18 April 2024
Biotech
Moderna COVID-19 vaccine dispute halted by court
A US District Court has granted a motion to stay the company’s lawsuit against Pfizer and BioNTech | Decision pauses proceedings until two inter partes review proceedings are resolved.   16 April 2024
Biotech
Court sides with Arbutus on claims in Moderna COVID vaccine patent row
Delaware district court more convinced by Arbutus on claim construction points | Canadian biotech “pleased” with outcome in latest round of dispute over lipid nanoparticles delivery system.   9 April 2024
Careers
In-house litigation expert joins Polsinelli
Former Biogen counsel brings expertise in patent litigation for startups- Fortune 500 biotech giants | Experience in gene sequencing, computational biology, diagnostic software, and biosimilars.   2 April 2024
Biotech
China IP office upholds CRISPR/Cas9 patent owned by Dublin biotech firm
ERS Genomics, founded by CRISPR co-inventor Emmanuelle Charpentier, celebrates as China rejects invalidity challenges | News follows on heels of a similar Japan Patent Office decision.   26 March 2024